Christophe Nicot

6.3k total citations · 3 hit papers
96 papers, 4.5k citations indexed

About

Christophe Nicot is a scholar working on Immunology, Ecology, Evolution, Behavior and Systematics and Agronomy and Crop Science. According to data from OpenAlex, Christophe Nicot has authored 96 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Immunology, 51 papers in Ecology, Evolution, Behavior and Systematics and 49 papers in Agronomy and Crop Science. Recurrent topics in Christophe Nicot's work include T-cell and Retrovirus Studies (80 papers), Vector-Borne Animal Diseases (51 papers) and Animal Disease Management and Epidemiology (49 papers). Christophe Nicot is often cited by papers focused on T-cell and Retrovirus Studies (80 papers), Vector-Borne Animal Diseases (51 papers) and Animal Disease Management and Epidemiology (49 papers). Christophe Nicot collaborates with scholars based in United States, France and China. Christophe Nicot's co-authors include Marcia Bellon, Chien‐Hung Yeh, Genoveffa Franchini, Ramona Moles, Xue Bai, Abhik Datta, Hicham H. Baydoun, Olivier Hermine, Julie Johnson and Renaud Mahieux and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Christophe Nicot

95 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FBXW7: a critical tumor suppressor of human cancers

2018 367 citations Chien‐Hung Yeh, Marcia Bellon et al. Molecular Cancer profile →
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy

2025 22 citations Christophe Nicot et al. Cytokine & Growth Factor Reviews profile →
Clinical approaches to overcome PARP inhibitor resistance

2025 20 citations Christophe Nicot et al. Molecular Cancer profile →

Peers

Countries citing papers authored by Christophe Nicot

Since Specialization

Citations

This map shows the geographic impact of Christophe Nicot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Nicot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Nicot more than expected).

Fields of papers citing papers by Christophe Nicot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Nicot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Nicot. The network helps show where Christophe Nicot may publish in the future.

Co-authorship network of co-authors of Christophe Nicot

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Nicot. A scholar is included among the top collaborators of Christophe Nicot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Nicot. Christophe Nicot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PARP inhibition elicits NK cell-associated immune evasion via potentiating HLA-G expression in tumor 2025 ·Drug Resistance Updates ·Siyuan Wang, (unknown), (unknown), Wen Pan, Pu Huang, (unknown), Xin Li, (unknown), Dan Liu, (unknown), (unknown), Christophe Nicot, Qinglei Gao	2
2	TGF-β-driven EMT in cancer progression and drug resistance 2025 ·Cytokine & Growth Factor Reviews ·Wen Luo, Qinfeng Shi, (unknown), Zhenwang Zhang, Russel J. Reiter, Milad Ashrafizadeh, Noushin Nabavi, Gautam Sethi, Christophe Nicot, Ying Mao	5
3	Jab1 regulates HRR mRNA stability to modulate PARP inhibitor sensitivity in triple-negative breast cancer 2025 ·Molecular Cancer ·Xin Peng, Yingying Wang, (unknown), (unknown), Shaolu Zhang, Zhenxing Zhong, Yongzhe Wang, Shanshan Liu, (unknown), Christophe Nicot, François X. Claret, Dexin Kong	0
4	HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation 2024 ·Pathogens ·Marcia Bellon, Christophe Nicot	10
5	NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression 2022 ·Molecular Cancer ·Huanhuan Sun, Hong Zhang, Yan Yan, Yushi Li, (unknown), Cuiling Zhou, Christophe Nicot, Haiqing Ma	34
6	FBXW7: a critical tumor suppressor of human cancers breakdown → 2018 ·Molecular Cancer ·Chien‐Hung Yeh, Marcia Bellon, Christophe Nicot	367
7	NOTCH1 Activation Depletes the Pool of Side Population Stem Cells in ATL 2017 ·PubMed ·Xue Bai, Chien‐Hung Yeh, Christophe Nicot	2
8	Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells 2015 ·Journal of Hematology & Oncology ·Xue Bai, Ramona Moles, (unknown), Christophe Nicot	30
9	Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions 2014 ·Molecular Cancer ·(unknown), Delphine Lemaçon, Hélène Fontaine, Marcia Bellon, Xue Bai, (unknown), Arnaud Coquelle, Christophe Nicot	27
10	Current views on the role of Notch signaling and the pathogenesis of human leukemia 2011 ·BMC Cancer ·Joanna Pancewicz, Christophe Nicot	39
11	Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1–associated adult T-cell leukemia 2010 ·Proceedings of the National Academy of Sciences ·Joanna Pancewicz, John M. Taylor, Abhik Datta, Hicham H. Baydoun, Thomas A. Waldmann, Olivier Hermine, Christophe Nicot	77
12	Celecoxib disrupts the canonical apoptotic network in HTLV-I cells through activation of Bax and inhibition of PKB/Akt 2007 ·APOPTOSIS ·Uma Sinha-Datta, John M. Taylor, Megan Brown, Christophe Nicot	21
13	Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication 2007 ·Journal of Biological Chemistry ·Uma Sinha-Datta, Abhik Datta, Sofiane Ghorbel, Madeleine Duc Dodon, Christophe Nicot	41
14	Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions 2005 ·Oncogene ·Christophe Nicot, Robert Harrod, Vincenzo Ciminale, Genoveffa Franchini	81
15	Human T-Cell Lymphotropic Virus Type 1 Tax Represses c-Myb-Dependent Transcription through Activation of the NF-κB Pathway and Modulation of Coactivator Usage 2001 ·Molecular and Cellular Biology ·Christophe Nicot, Renaud Mahieux, Cynthia A. Pise-Masison, John Brady, Antoine Gessain, Shoji Yamaoka, Genoveffa Franchini	32
16	Distinct p300-Responsive Mechanisms Promote Caspase-Dependent Apoptosis by Human T-Cell Lymphotropic Virus Type 1 Tax Protein 2000 ·Molecular and Cellular Biology ·Christophe Nicot, Robert Harrod	47
17	The MHC Class I Heavy Chain Is a Common Target of the Small Proteins Encoded by the 3′ End of HTLV Type 1 and HTLV Type 2 2000 ·AIDS Research and Human Retroviruses ·Julie Johnson, James C. Mulloy, Vincenzo Ciminale, Jake Fullen, Christophe Nicot, Genoveffa Franchini	26
18	Inactivation of p53 by HTLV Type 1 and HTLV Type 2 Tax trans -Activators 2000 ·AIDS Research and Human Retroviruses ·Renaud Mahieux, Cynthia A. Pise-Masison, Christophe Nicot, (unknown), William W. Hall, John Brady	24
19	Activation of Bcl-2 Expression in Human Endothelial Cells Chronically Expressing the Human T-Cell Lymphotropic Virus Type I 1997 ·Virology ·Christophe Nicot, (unknown), Bernard Guillemain	30
20	Establishment of HTLV-I-infected cell lines from French, Guianese and West Indian patients and isolation of a proviral clone producing viral particles 1993 ·Virus Research ·Christophe Nicot, (unknown), (unknown), E. Legrand, (unknown), Anne Vital, Danielle Londos‐Gagliardi, Jean‐Paul Moreau, Bernard Guillemain	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact